Pharmaceutical Supply – Diphenhydramine Hydrochloride Capsules

The contract calls for the supply of FDA-approved Diphenhydramine Hydrochloride capsules in full compliance with federal labeling, packaging, and hazardous material regulations, ensuring adherence to all applicable safety and regulatory standards for pharmaceutical distribution. The product must meet stringent quality controls required by the FDA and be packaged and labeled according to federal guidelines, including proper handling of hazardous materials as defined by transportation and storage requirements. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance required at Quantico, Virginia, 22134-5019, and the solicitation period opened on July 15, 2026, with responses due by July 21, 2026. The NAICS code 325412 indicates the scope pertains to pharmaceutical and biological product manufacturing, and the effort is part of a broader defense medical logistics initiative to secure critical pharmaceutical inventory.